| Autor: |
Polyakov DS; «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia., Fomin IV; «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia., Belenkov YN; Sechenov Moscow State Medical University, Moscow, Russia., Mareev VY; Medical Research and Educational Center of the M. V. Lomonosov Moscow State University, Moscow, Russia Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia., Ageev FT; Scientific Medical Research Center of Cardiology, Moscow, Russia., Artemjeva EG; State Autonomous Institution of the Chuvash Republic Postgraduate Doctors Training Institute of HealthCare Ministry, Russia., Badin YV; «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia., Bakulina EV; Kirov state medical University, Russia., Vinogradova NG; «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia City Clinical Hospital #38, Nizhny Novgorod, Russia., Galyavich AS; Kazan State Medical University of the Ministry of Health of the Russian Federation, Kazan, Russia., Ionova TS; Regional Clinical Cardiological Dispensary, Saratov, Russia., Kamalov GM; Kazan State Medical University of the Ministry of Health of the Russian Federation, Kazan, Russia., Kechedzhieva SG; Stavropol State Medical Universityof the Ministry of Health of the Russian Federation, Stavropol, Russia., Koziolova NA; Perm State Medical University named after Academician E.A. Wagner, Perm, Russia., Malenkova VY; Budget institution Republican clinical hospital of the Ministry of health of the Chuvash Republic., Malchikova SV; Kirov state medical University, Russia., Mareev YV; National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia Robertson Centre for Biostatistics, Glasgow, Great Britain., Smirnova EA; Ryazan State Medical University of the Ministry of Health of the Russian Federation, Ryazan, Russia., Tarlovskaya EI; «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia., Shcherbinina EV; «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia., Yakushin SS; Ryazan State Medical University of the Ministry of Health of the Russian Federation, Ryazan, Russia. |
| Abstrakt: |
Aim To study the etiology and the dynamics of prevalence and mortality of CHF; to evaluate the treatment coverage of such patients in a representative sample of the European part of the Russian Federation for a 20-year period. Material and methods A representative sample of the European part of the Russian Federation followed up for 2002 through 2017 (n=19 276); a representative sample of the population of the Nizhny Novgorod region examined in 1998 (n=1922).Results During the observation period since 2002, the incidence of major CHF symptoms (tachycardia, edema, shortness of breath, weakness) tended to decrease while the prevalence of cardiovascular diseases has statistically significantly increased. During the period from 1998 through 2017, the prevalence of I-IV functional class (FC) CHF increased from 6.1 % to 8.2 % whereas III-IV FC CHF increased from 1.8 % to 3.1 %. The main causes for the development of CHF remained arterial hypertension and ischemic heart disease; the role of myocardial infarction and diabetes mellitus as causes for CHF was noted. For the analyzed period, the number of treatment components and the coverage of basic therapy for patients with CHF increased, which probably accounts for a slower increase in the disease prevalence by 2007-2017. The prognosis of patients was unfavorable: in I-II FC CHF, the median survival was 8.4 (95 % CI: 7.8-9.1) years and in III-IV FC CHF, the median survival was 3.8 (95 % CI: 3.4-4.2) years. |
